studi
aim
describ
reallif
microbiolog
test
adult
hospitalis
communityacquir
pneumonia
cap
assess
concord
communityacquir
pneumonia
cap
lead
caus
hospitalis
worldwid
mortal
rate
patient
hospitalis
cap
approach
especi
admit
intens
care
unit
icu
diagnost
test
cap
potenti
improv
individu
patient
manag
reduc
risk
clinic
failur
death
gener
epidemiolog
data
inform
select
appropri
empir
antibiot
therapi
unfortun
advantag
counterbalanc
high
healthcar
cost
associ
diagnost
test
low
sensit
test
identifi
pathogen
caus
cap
consid
benefit
limit
diagnost
test
sever
intern
scientif
societi
publish
guidelin
effect
diagnost
test
strategi
hospitalis
patient
cap
howev
import
differ
exist
recommend
differ
societi
recommend
mainli
base
expert
opinion
given
scarciti
publish
evid
particular
substanti
differ
found
two
cite
intern
guidelin
cap
infecti
diseas
societi
america
idsa
american
thorac
societi
at
european
respiratori
societi
er
guidelin
limit
data
avail
reallif
diagnost
test
practic
hospitalis
patient
cap
whether
reallif
diagnost
test
practic
concord
idsaat
er
guidelin
recommend
studi
aim
describ
reallif
microbiolog
test
adult
hospitalis
cap
evalu
influenc
geographi
diseas
sever
microbiolog
test
practic
assess
concord
reallif
microbiolog
test
two
cite
intern
guidelin
specif
idsaat
er
guidelin
perform
secondari
analysi
intern
multicentr
observ
prospect
cohort
studi
use
global
initi
methicillinresist
staphylococcu
aureu
pneumonia
glimp
databas
glimp
conduct
among
hospit
countri
day
day
per
month
randomli
select
march
april
may
june
adult
patient
age
year
hospitalis
cap
particip
centr
four
studi
day
screen
glimp
investig
includ
secondari
analysi
patient
hospitalis
diagnosi
hospitalacquir
ventilatorassoci
pneumonia
exclud
glimp
coordin
centr
locat
univers
texa
health
san
antonio
san
antonio
tx
usa
coordin
centr
receiv
expedit
project
approv
institut
review
board
number
review
board
waiv
need
receipt
inform
consent
due
natur
studi
institut
review
board
approv
obtain
site
investig
individu
centr
detail
descript
glimp
organis
methodolog
previous
publish
primari
outcom
studi
describ
reallif
microbiolog
test
among
patient
hospitalis
cap
includ
frequenc
test
laboratori
techniqu
use
patient
characterist
test
statu
test
patient
versu
test
patient
studi
also
two
secondari
outcom
first
evalu
influenc
geographi
diseas
sever
test
practic
icu
admiss
invas
mechan
ventil
vasopressor
combin
administr
vasopressor
invas
mechan
ventil
use
measur
diseas
sever
second
evalu
concord
reallif
microbiolog
test
idsaat
er
guidelin
cap
cap
defin
evid
new
pulmonari
infiltr
thorac
imag
chest
radiograph
comput
tomographi
ultrasound
first
h
hospitalis
least
one
follow
criteria
new
increas
cough
without
sputum
product
purul
respiratori
secret
fever
hypothermia
document
rectal
oral
temperatur
respect
evid
system
inflamm
abnorm
white
blood
cell
count
leukocytosi
leukopenia
bandaemia
increas
creactiv
protein
procalcitonin
concentr
local
upper
limit
normal
hospitalis
defin
admiss
inpati
servic
subsequ
stay
h
methicillinresist
staphylococcu
aureu
defin
accord
clinic
laboratori
standard
institut
clsi
guidelin
minimum
inhibitori
concentr
oxacillin
product
extendedspectrum
defin
accord
clsi
guidelin
via
broth
microdilut
disk
diffus
clavulan
inhibit
test
diagnost
test
defin
concord
idsaat
guidelin
recommend
test
perform
nonrecommend
test
perform
similarli
diagnost
test
defin
concord
er
guidelin
recommend
test
perform
nonrecommend
test
perform
test
consid
studi
recommend
nonrecommend
idsaat
er
guidelin
present
tabl
overtest
defin
condit
test
requir
perform
undertest
defin
condit
requir
test
perform
continu
variabl
present
median
interquartil
rang
categor
variabl
present
frequenc
percentag
specifi
group
comparison
group
made
fisher
exact
test
kruskalw
test
appropri
twosid
pvalu
consid
statist
signific
statist
analys
perform
use
spss
statist
version
softwar
ibm
armonk
ny
usa
among
patient
least
one
diagnost
test
perform
patient
least
one
pathogen
detect
diagnost
test
variabl
significantli
associ
perform
diagnost
test
present
tabl
patient
least
one
pathogen
detect
compar
patient
pathogen
detect
found
former
group
commonli
present
follow
condit
bronchiectasi
tracheostomi
least
one
respiratori
comorbid
hypertens
hiv
infect
perviou
infect
previou
healthcar
exposur
sever
cap
icu
admiss
mechan
ventil
use
vasopressor
tabl
oceania
patient
admit
african
hospit
p
pneumococc
legionella
urinari
antigen
test
perform
patient
admit
european
hospit
patient
hospitalis
remain
contin
p
acutephas
serolog
chlamydophila
pneumonia
mycoplasma
pneumonia
legionella
speci
common
europ
elsewher
p
diagnost
test
concord
idsaat
er
recommend
patient
respect
overal
studi
popul
analys
overtest
undertest
report
idsaatsdiscord
patient
respect
figur
among
idsaatsdiscord
patient
blood
cultur
perform
without
indic
account
major
overtest
lack
pneumococc
urinari
antigen
test
respons
signific
percentag
undertest
overtest
undertest
document
ersdiscord
patient
respect
figur
among
ersdiscord
patient
pneumococc
legionella
urinari
antigen
test
perform
without
indic
account
major
overtest
undertest
mainli
due
lack
obtain
blood
cultur
indic
idsaat
concord
common
europ
north
america
versu
p
er
concord
common
north
america
europ
versu
p
intern
multicentr
pointpreval
studi
provid
highqual
reallif
pictur
diagnost
test
patient
hospitalis
cap
least
one
microbiolog
test
perform
vast
major
patient
hospitalis
cap
led
aetiolog
diagnosi
onethird
patient
test
geograph
area
diseas
sever
influenc
test
frequenc
studi
also
highlight
signific
discord
reallif
diagnost
test
compar
recommend
test
idsa
at
er
guidelin
cap
manag
adult
sever
crucial
point
could
rais
find
first
pathogen
identifi
onethird
adult
inpati
cap
pathogendetect
yield
similar
previous
report
investig
consist
epic
etiolog
pneumonia
commun
studi
despit
extens
laboratori
test
epic
studi
identifi
pathogen
patient
hospitalis
cap
usa
low
pathogendetect
yield
report
cap
studi
highlight
limit
understand
cap
aetiolog
among
adult
inpati
current
empir
antimicrobi
recommend
base
weak
evid
studi
aim
collect
much
data
possibl
identifi
aetiolog
use
stateoftheart
diagnost
techniqu
innov
pathogendiscoveri
approach
urgent
need
furthermor
aetiolog
studi
use
novel
analyt
techniqu
order
incorpor
evid
multipl
specimen
account
imperfect
sensit
specif
diagnost
test
use
accur
estim
aetiolog
distribut
cap
among
adult
inpati
avail
empir
antimicrobi
recommend
updat
secondli
studi
show
exist
strong
associ
pneumonia
sever
perform
diagnost
test
accord
idsaat
er
recommend
consequ
pneumonia
sever
also
associ
increas
probabl
pathogen
detect
explor
true
determin
pathogen
detect
would
requir
systemat
univers
test
strategi
reason
scope
studi
thirdli
studi
confirm
differ
diagnost
yield
variou
diagnost
test
specif
blood
cultur
yield
posit
result
confirm
low
sensit
blood
cultur
reveal
aetiolog
cap
similar
find
studi
contrast
bal
cultur
characteris
high
diagnost
yield
impract
potenti
associ
complic
bal
cultur
repres
effect
diagnost
tool
patient
sever
infect
may
benefit
target
antimicrobi
regimen
inde
randomis
trial
van
der
eerden
et
al
show
statist
signific
differ
mortal
among
icu
patient
receiv
empir
broadspectrum
antimicrobi
versu
patient
receiv
pathogendirect
antimicrobi
fourthli
analysi
describ
signific
geograph
variat
diagnost
test
strategi
could
specul
econom
restraint
african
health
system
account
reduc
number
blood
cultur
viral
test
perform
set
laboratori
infrastructur
support
diagnost
microbiolog
test
limit
african
countri
bacteriolog
cultur
molecular
techniqu
form
mainstay
cap
diagnost
wellresourc
set
often
lack
africa
contrast
season
epidemiolog
relev
respiratori
virus
avianorigin
influenza
middl
east
respiratori
syndrom
coronaviru
may
favour
perform
viral
test
asia
fifthli
studi
among
first
evalu
concord
reallif
diagnost
test
intern
guidelin
best
knowledg
jenkin
et
al
made
similar
attempt
analys
concord
diagnost
test
practic
retrospect
cohort
adult
inpati
cap
idsaat
guidelin
report
overtest
blood
cultur
studi
reveal
reallif
diagnost
test
concord
idsaat
er
guidelin
vast
major
patient
specif
discord
idsaat
guidelin
mainli
due
overtest
situat
may
explain
restrict
test
recommend
idsaat
guidelin
note
undertest
also
caus
discord
idsaat
guidelin
frequent
encount
north
america
europ
discord
er
guidelin
mainli
due
undertest
result
extens
test
approach
recommend
guidelin
overtest
also
identifi
caus
discord
er
guidelin
event
frequent
report
europ
north
america
intrigu
european
clinician
extens
order
diagnost
test
even
beyond
recommend
er
guidelin
insur
healthcar
systemrel
factor
may
shape
diagnost
approach
european
north
american
clinician
nonetheless
signific
discrep
reallif
diagnost
test
idsaats
recommend
test
worrisom
studi
aim
assess
clinic
econom
implic
test
approach
propos
idsaat
guidelin
test
approach
propos
er
guidelin
reallif
diagnost
test
need
final
studi
import
strength
limit
knowledg
glimp
first
studi
enrol
larg
divers
group
adult
patient
hospitalis
cap
across
six
contin
provid
detail
realworld
pictur
cap
diagnost
test
around
world
abil
assess
concord
reallif
diagnost
test
idsaat
er
guidelin
recommend
affect
lack
inform
recent
travel
failur
outpati
antibiot
therapi
presenc
cavitari
infiltr
lymphopenia
feasibl
sputum
collect
glimp
databas
similarli
incomplet
data
regard
presenc
pleural
effus
clinic
epidemiolog
determin
legionella
infect
limit
accuraci
find
probabl
lead
inflat
overtest
estim
final
due
crosssect
design
studi
provid
cap
outcom
data
conclus
understand
aetiolog
cap
among
hospitalis
adult
scarc
limit
accuraci
empir
antimicrobi
regimen
diseas
sever
geographi
associ
differ
test
approach
wide
discord
idsaats
recommend
reallif
test
strategi
prompt
futur
studi
evalu
clinic
econom
implic
differ
test
approach
investig
reason
differ
